Overview

Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized trial is to compare the efficacy and tolerability of H. pylori eradication with a 5-day quadruple therapy versus a clarithromycin-containing triple therapy.
Phase:
N/A
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Clarithromycin
Esomeprazole
Metronidazole
Tetracycline